There is no FDA-approved human trial yet
I am not convinced the data is fully there yet." Tatem said he expects the hearings to be a "hard-fought battle," but hopes committee members will consider what he described as real-world data from tens of millions of doses administered between 2014 and 2023
The FDA concludes that more information is needed to determine potential harm
The NHS symptoms list groups them into general anaemia symptoms (tiredness, breathlessness, headaches, loss of appetite, weight loss) and neurological signs (peripheral neuropathy, balance problems, depression, memory and concentration changes, sometimes mood changes or psychosis in advanced cases)
Glucagon receptor activation: Increases energy expenditure by promoting fat oxidation and thermogenesis